Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward

BACKGROUND: Changes in driving behaviour may start at the preclinical stage of Alzheimer’s disease (AD), where the underlying AD biological process has begun in the presence of cognitive normality. Here, we summarize the emerging evidence suggesting that preclinical AD may impact everyday driving be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayat, Sayeh, Roe, Catherine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641948/
https://www.ncbi.nlm.nih.gov/pubmed/36348410
http://dx.doi.org/10.1186/s13195-022-01109-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641948/
https://www.ncbi.nlm.nih.gov/pubmed/36348410
http://dx.doi.org/10.1186/s13195-022-01109-1

Ejemplares similares